BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) 

BioIncubator Unit
Bessemer Building (RSM) Level 1

Prince Consort Road
London    SW7 2BP  United Kingdom
Phone: 44-0-20-7594-1326 Fax: 44-0-7968-183-512


SEARCH JOBS


Industry
Medical Device






 Company News
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Receives Visit from His Royal Highness, Prince Andrew, Duke of York 3/2/2011 10:34:07 AM    More...
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Seeks US FDA 510(k) Clearance for StronBone(TM) 2/9/2011 9:29:34 AM    More...
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Raises £1.03m ($1.6m) in Additional Capital from Existing Investors Imperial Innovations, Longbow Capital and Others 11/16/2010 10:52:41 AM    More...
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics)'s Chief Science Officer, Dr. Molly Stevens, is Named One of the Top-10 Scientists Under the Age of 40 in Britain 10/20/2010 10:38:16 AM    More...
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Discloses Six-Month in Vivo Data Confirming Bone-Regeneration Properties of Stronbone(TM) Bone Graft Substitute - the First Product from the Company's Platform to Repair and Regenerate Hard Tissue, Such as Bone 9/30/2010 9:41:48 AM    More...
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Is Recognized As One Of The UK's 'Top 50 University Spin-Out Companies' By Britain's Largest-Selling Daily Newspaper, The Daily Telegraph 8/5/2010 10:16:39 AM    More...
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics)(TM) Reports Data from an In Vivo Study of StronBon(TM) Bone Graft Substitute — The First Product from the Company’s Platform to Repair and Regenerate Hard Tissue, Such as Bone 6/1/2010 10:02:24 AM    More...
RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) CEO Ian Brown is Invited to Speak at the 50th Global Entrepreneurship Forum of the INSEAD Leadership Summit 5/13/2010 10:05:47 AM    More...
BioCeramic Therapeutics Appoints Ian Brown To CEO 1/13/2010 9:53:56 AM    More...
Dr Stephan Rietiker Joins BioCeramic Therapeutics' Board; Company Embarks on New Fundraising Round 1/9/2009 7:33:48 AM    More...
12

//-->